[1]
“Review on Formulation and Development of Controlled Porosity Osmotic Tablet of Repaglinide”, Int. J. Life. Sci. Biotech. Pharm. Sci, vol. 12, no. 2, pp. 10–16, May 2016, Accessed: Mar. 12, 2026. [Online]. Available: https://ijlbps.net/index.php/ijlbps/article/view/37